top of page

FlowOx™

Multiple Sclerosis: Understanding the Condition and Its Daily Impact

Multiple Sclerosis (MS) is a chronic, immune‑mediated neurological condition affecting more than 33,000 Australians and millions worldwide. Characterised by inflammation and damage to the central nervous system, MS disrupts communication between the brain and body, leading to a wide range of symptoms that vary in severity and progression.

While every person’s MS journey is different, many experience symptoms that significantly affect daily comfort, mobility, sleep, and independence. These symptoms often fluctuate, creating ongoing challenges for clinicians aiming to optimise long‑term functional outcomes.

Key Symptoms Commonly Experienced by People Living With MS

  • Spasticity and muscle stiffness -often affecting the lower limbs, limiting mobility and increasing discomfort.

  • Night‑time spasms- contributing to sleep disruption and increased fatigue.

  • Neuropathic pain and sensory changes- including burning, tingling, or tightness.

  • Reduced circulation and lower‑limb swelling- frequently exacerbated by reduced mobility.

  • Fatigue- one of the most disabling symptoms, impacting daily function and participation.

  • Sleep disturbance-driven by spasms, discomfort, and autonomic dysregulation.

  • Functional limitations-affecting gait, transfers, balance, and independence.

These symptoms often interact, creating a cycle where discomfort reduces mobility, reduced mobility worsens circulation, and poor sleep amplifies fatigue and spasticity.

Why Home‑Based Symptom Management Matters

  • For many people with MS, consistent daily management is essential — but difficult to achieve through clinic‑based interventions alone. Clinicians increasingly seek safe, non‑pharmacological, home‑based therapies that support:

  • Better symptom control between appointments

  • Improved sleep and reduced night‑time spasms

  • Enhanced comfort and mobility

  • Greater independence and self‑management

  • Reduced reliance on medication for spasticity and pain

  • Improved quality of life through predictable daily routines

  • This is where FlowOx™ plays a meaningful role.

FlowOx Leg & Boot.png

FlowOx™ advantages

  • Non-invasive, safe and easy to use

  • Suitable for home use

  • Can be used in addition to surgical intervention or where surgery is contraindicated

  • May be used on limbs with existing wounds if they are bandaged.

FlowOx™: A Practical, Evidence‑Supported Option for MS Symptom Relief

FlowOx™ is a CE‑marked Class IIa medical device designed to deliver gentle, intermittent pressure therapy to the lower legs. Used for just one hour per day, FlowOx™ supports circulation, neuromuscular relaxation, and symptom reduction- all from home.

Clinical trials and real‑world data demonstrate meaningful improvements for people living with MS, including:

  • Reduced spasticity

  • Fewer night‑time spasms

  • Improved sleep quality

  • Less daytime fatigue

  • Better comfort and mobility

  • Enhanced independence through daily self‑management

FlowOx™ is now TGA approved in Australia for MS use and is being adopted internationally as a supportive therapy for managing MS‑related spasticity and associated symptoms.

Heal-Med Solutions medical devices & consumables

Contact us:


Heal-Med Solutions Pty Ltd (HMS) is an Australian-owned and operated company based in Sydney. We are not affiliated with any overseas organisations using similar names. All products, services and communications on this website relate exclusively to Heal-Med Solutions Pty Ltd, Australia. 

Heal-Med Solutions specialise in medical device & consumable technology and biotechnology sectors. HMS provides a comprehensive suite of services to collaborate with international medical device and healthcare companies entering or expanding within the Australia & New Zealand markets. ​

Follow us:
  • LinkedIn
  • Facebook
Quick Links 

Copyright @2026 by Heal-Med Solutions Pty Ltd

All rights reserved. Terms of Use | Privacy | Powered and secured by Wix

bottom of page